Whereas treatment with anti-neu mAb resulted in strong tumour regression in WT BALB/c mice, tumours relapsed progressively in the absence of T cells, suggesting that T cells are essential for the maximal therapeutic efficacy of anti-neu mAb. The gene discussed is ERBB2; the disease is neoplasm.